Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
Abstract While existing remedies failed to fully address the consequences of heart failure, stem cell therapy has been introduced as a promising approach. The present review is a comprehensive appraisal of the impacts of using mesenchymal stem cells (MSCs) in clinical trials mainly conducted on isch...
Main Authors: | Iman Razeghian-Jahromi, Anthony G. Matta, Ronan Canitrot, Mohammad Javad Zibaeenezhad, Mahboobeh Razmkhah, Anahid Safari, Vanessa Nader, Jerome Roncalli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02443-1 |
Similar Items
-
Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
by: Wei Gao, et al.
Published: (2023-07-01) -
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Seyed Mahmood Nouraei, et al.
Published: (2007-07-01) -
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Ali Ghayemian, et al.
Published: (2007-08-01) -
Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
by: Zhi-hua Zhang, et al.
Published: (2020-03-01) -
Clinical mesenchymal stem cell therapy in ischemic cardiomyopathyCentral Message
by: Amine Mazine, MD, MSc, et al.
Published: (2021-12-01)